MedinCell S.A. Stock Börse Stuttgart
Stocks
MEB
FR0004065605
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.06B 0 1.21B 974M 908M 1.72B 115B 1.75B 11.67B 4.55B 56.77B 4.55B 4.45B 196B | P/E 2026 * |
-69.8x | P/E 2027 * | 554x |
|---|---|---|---|---|---|
| Enterprise Value | 1.04B 0 1.19B 959M 894M 1.7B 114B 1.72B 11.49B 4.48B 55.91B 4.48B 4.38B 193B | EV / Sales 2026 |
32.7x | EV / Sales 2027 * | 23.3x |
| Free-Float |
70.46% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MedinCell S.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 62 | 09/01/2003 |
Stéphane Postic
DFI | Director of Finance/CFO | 52 | 01/09/2023 |
Richard Malamut
CTO | Chief Tech/Sci/R&D Officer | 67 | 09/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Douat
BRD | Director/Board Member | 62 | 09/01/2003 |
Philippe Guy
CHM | Chairman | - | 13/03/2024 |
Virginie Lleu
BRD | Director/Board Member | - | 25/05/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.21B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| -0.26% | +1.37% | +31.00% | +23.97% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +1.47% | +4.45% | +30.96% | +57.78% | 410.27B | |
| Weighted average by Cap. | +1.87% | +5.43% | +41.75% | +82.98% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 31.96M 0 36.55M 29.37M 27.38M 51.91M 3.48B 52.69M 352M 137M 1.71B 137M 134M 5.9B | 44.78M 0 51.21M 41.15M 38.36M 72.73M 4.88B 73.82M 493M 192M 2.4B 192M 188M 8.27B |
| Net income | -13.98M -0 -15.99M -12.85M -11.98M -22.71M -1.52B -23.05M -154M -59.98M -749M -59.99M -58.71M -2.58B | 786K 0 899K 722K 673K 1.28M 85.57M 1.3M 8.65M 3.37M 42.08M 3.37M 3.3M 145M |
| Net Debt | -16.07M -0 -18.37M -14.77M -13.76M -26.1M -1.75B -26.49M -177M -68.93M -861M -68.94M -67.48M -2.97B | -14.87M -0 -17M -13.66M -12.74M -24.15M -1.62B -24.51M -164M -63.78M -796M -63.79M -62.44M -2.74B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
